Endosaccular treatment of 113 cavernous carotid artery aneurysms

被引:25
作者
Choulakian, Armen [1 ]
Drazin, Doniel [1 ]
Alexander, Michael J. [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA
关键词
BALLOON TEST OCCLUSION; SINUS ANEURYSMS; NATURAL-HISTORY; ENDOVASCULAR TREATMENT; CLINICAL PRESENTATION; EMBOLIZATION; MANAGEMENT; THERAPY; COILS;
D O I
10.1136/jnis.2010.003137
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Objective Cavernous carotid aneurysms (CCAs) can present with visual symptoms or with subarachnoid hemorrhage (SAH). As surgical treatment of these aneurysms can be technically challenging, endovascular management has emerged as the preferred treatment modality. Methods A retrospective review was conducted of 113 patients who underwent endosaccular treatment for CCAs. Presenting symptoms, aneurysm size, use of stent assistance, rate of thromboembolic complications, presence of SAH and angiographic follow-up were reviewed. Results 29 patients (26%) with CCAs presented with diplopia due to cranial nerve palsies. Mean aneurysm size in this group was 17 mm. Three patients (2.6%) presented with SAH with a mean aneurysm size of 15.3 mm. Mean length of stay for ruptured versus non-ruptured aneurysms was 11.7 and 1.7 days, respectively. Clinically significant thromboembolic complications occurred in four cases (3.5%). Stent assistance was required in 53 cases (47%). Of the 86 patients (76%) returning for follow-up angiography (mean 6.2 months), 58 (75%) had no residual aneurysm and 14 (12%) showed regrowth. Thirteen patients (11.5%) underwent repeat endovascular treatment. Conclusions CCAs commonly produce diplopia and cranial nerve palsies when a critical size is reached (mean 17 mm in our series). Aneurysm obliteration with internal carotid artery preservation is the preferred treatment modality and can be accomplished with coil embolization with or without stent assistance. Although recurrence and retreatment can occur, the thromboembolic risk of endovascular treatment is low. Consideration should be given to treatment of asymptomatic CCAs 15 mm or larger due to potential risks of cranial neuropathy and SAH.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 20 条
[1]  
Bavinzski G, 1998, AM J NEURORADIOL, V19, P559
[2]   Presentation and treatment of carotid cavernous aneuryms [J].
de Vasconcellos, Lucas Perez ;
Castro Flores, Juan Antonio ;
Esteves Veiga, Joso Carlos ;
Marques Conti, Mario Luiz ;
Shiozowa, Pedro .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2008, 66 (2A) :189-193
[3]   Advanced noninvasive imaging of spinal vascular malformations [J].
Eddleman, Christopher S. ;
Jeong, Hyun ;
Cashen, Ty A. ;
Walker, Matthew ;
Bendok, Bernard R. ;
Batjer, H. Hunt ;
Carroll, Timothy J. .
NEUROSURGICAL FOCUS, 2009, 26 (01)
[4]  
Field M, 2003, AM J NEURORADIOL, V24, P1200
[5]   Long term visual and neurological prognosis in patients with treated and untreated cavernous sinus aneurysms [J].
Goldenberg-Cohen, N ;
Curry, C ;
Miller, NR ;
Tamargo, RJ ;
Murphy, KPJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (06) :863-867
[6]   Giant cavernous carotid aneurysms: Clinical presentation in fifty-seven cases [J].
Hahn, CD ;
Nicolle, DA ;
Lownie, SP ;
Drake, CG .
JOURNAL OF NEURO-OPHTHALMOLOGY, 2000, 20 (04) :253-258
[7]  
Halbach VV, 1997, J NEURO-OPHTHALMOL, V17, P231
[8]   ENDOVASCULAR DETACHABLE BALLOON EMBOLIZATION THERAPY OF CAVERNOUS CAROTID-ARTERY ANEURYSMS - RESULTS IN 87 CASES [J].
HIGASHIDA, RT ;
HALBACH, VV ;
DOWD, C ;
BARNWELL, SL ;
DORMANDY, B ;
BELL, J ;
HIESHIMA, GB .
JOURNAL OF NEUROSURGERY, 1990, 72 (06) :857-863
[9]   FOLLOW-UP-STUDY OF UNRUPTURED ANEURYSMS ARISING FROM THE C3-SEGMENT AND C4-SEGMENT OF THE INTERNAL CAROTID-ARTERY [J].
INAGAWA, T .
SURGICAL NEUROLOGY, 1991, 36 (02) :99-105
[10]   Treatment strategy for giant aneurysms in the cavernous portion of the internal carotid artery [J].
Kai, Yutaka ;
Hamada, Jun-ichiro ;
Morioka, Motohiro ;
Yano, Shigetoshi ;
Mizuno, Takamasa ;
Kuroda, Jun-ichiro ;
Todaka, Tatemi ;
Takeshima, Hideo ;
Kuratsu, Jun-ichi .
SURGICAL NEUROLOGY, 2007, 67 (02) :148-155